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Abstract
Neonatal blue-light phototherapy induced a blistering reaction followed by erup-
tion of melanocytic nevi on the exposed skin surface of a child with transient
neonatal porphyrinemia. New nevi are still developing 4 years after the triggering
event. The role of phototoxicity-induced epidermal injury, that of porphyrins and
the influence of neonatal blue-light therapy, in this unique phenomenon are dis-
cussed.
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1 | INTRODUCTION
Eruptive melanocytic nevi are a rare phenomenon characterized by
rapid development of numerous melanocytic proliferations in a previ-
ously unaffected skin area. It has been observed in association with
blistering diseases, erosions, scaring, ultraviolet light exposure, local
or systemic immunosuppression, hormonal influences, and, occasion-
ally, without any apparent precipitating factors.
2 | CASE REPORT
A 10-month-old boy was referred for consultation because of hyperpig-
mented macules arranged in a rectangular shape on his chest and abdo-
men. Physical examination revealed a well-developed child with light hair
and blue eyes. He had a sharply demarcated area on the ventral surface
of the trunk with pitted scars and multiple, partially confluent brown
macules, 3-5 mm in diameter (Figure 1A). There was a larger (~20 mm)
brown patch with darker spots on the side of the abdomen.
He had been born in the 40th week of gestation (Apgar scores
10, A Rh positive) by caesarean section, performed because of fetal
bradycardia. For 2 weeks before delivery, the mother (A Rh positive)
had been treated with ampicillin for a urinary tract infection.
By 2 days of age, jaundice developed in the newborn (total biliru-
bin level 176.5 lmol/L, with a direct fraction of 6.8 lmol/L). Neonatal
blue-light phototherapy (NBLP) (Bili-Bed, Uniwill Co., Budapest, Hun-
gary) was initiated and continued for 12 hours. Approximately
16 hours after the start of NBLP, erythema appeared on the exposed
skin of the arms, thighs, chest, and abdomen. Later, small vesicles and
a few large bullae developed, mainly at the margins of the erythema-
tous surface of the trunk. Before the onset of the skin lesions, the
newborn had not received any drugs. Plasma and erythrocyte
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porphyrin levels were high, urine and stool porphyrin concentrations
were normal (Table 1). There was no family history of porphyria, light
sensitivity, pigment disorder, or melanoma. Systemic (ampicillin) and
local (0.5% neomycin sulfate with 1% salicylic acid ointment) treat-
ments were started, and the blisters resolved within 1 week. By that
time, the jaundice had also subsided.
Approximately 3 months later, brown macules appeared on the
previously affected skin of the trunk (Figure 1A). The skin had not
been exposed to sunlight before the eruption of pigmented lesions.
At the age of 10 months, porphyrin levels in the erythrocytes,
plasma, and urine were in the normal range; stool porphyrins were
not determined (Table 1). The spectrum of the phototherapy lamp
was checked; its emission range and irradiance provided are shown
in Figure 2.
During follow-up, a gradual increase in the number and darkness
of the skin lesions was observed (Figure 1B). Histology at 3 years of
age revealed junctional melanocytic proliferations with nevus cell
nests in the follicular epithelium (Figure 3). Clinical, laboratory, and
histologic findings suggested the diagnosis of transient neonatal por-
phyrinemia and eruptive melanocytic nevi.
3 | DISCUSSION
Blue-light phototherapy is an effective way to reduce plasma biliru-
bin concentrations and is widely used to treat neonatal jaundice.
Side effects of NBPL are rare, but cutaneous reactions, high
transepidermal water loss, abdominal distension, mild hemolysis, and
thrombocytopenia have occasionally been reported. Cutaneous side
(A) (B)
F IGURE 1 After erythema and blistering induced by a single session of blue-light phototherapy, brown macules and pitted scars developed
on the exposed skin surface of the chest and abdomen of the infant boy. During follow-up, a gradual increase in number and darkness of the
skin lesions was observed (the skin of the patient at 10 mo (A) and 4 y (B) of age)
TABLE 1 Porphyrin levels at 5 d and 10 mo of age
Porphyrin 5 d 10 mo Reference value
Erythrocyte, lg/dL 107 35 <50
Plasma, lg/dL 1.7 0.2 <1.2
Urine, lg/d 1.3 8.7 <200
Stool, lg/g 10.9 - <50
F IGURE 2 Spectrum of the blue-light
phototherapy unit
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effects include ultraviolet burns, blistering eruptions, purpuric lesions,
and diffuse darkening of the skin (bronze baby syndrome). Eruption
of purpura and blisters has been observed in newborns with tran-
sient or hereditary porphyrias.1,2
Transient porphyrinemia in newborns seems to be rare, the pre-
sent being the tenth case reported.2-6 All cases were detected
because of adverse reactions to phototherapy. The etiology is
unclear and may be multifactorial. The concentration of protopor-
phyrin within erythrocytes may rise when iron deficiency becomes
manifest in disturbed heme synthesis.7 Preterm infants have highly
variable iron status, but infants born at term usually have sufficient
iron stores until 4-6 months of age. Abnormal liver or renal functions
may interfere with the porphyrin metabolism and excretion, and high
transaminase levels, cholestasis, and mild renal dysfunction have
been observed in some affected newborns,2,4 but this does not
explain the high erythrocyte porphyrin levels previously reported
and seen in the present newborn. Drugs and heavy metals may like-
wise act as possible causal agents, but their role did not emerge in
any of the cases. Porphyrin levels had returned to normal by the age
of 4 to 5 months in all of the infants reported. The acute cutaneous
symptoms resolved spontaneously without any permanent sequelae,
or resulted in localized atrophy, scarring or milia.2-6
We found no clue to the etiology of transient porphyrinemia in
the present patient. The acute phototoxic reaction was similar to
those reported previously, but the eruption of melanocytic nevi
3 months after the blistering reaction is unique.
Rarely, blistering skin diseases may induce sudden development
of multiple melanocytic nevi.8 It has been described in patients with
erythema multiforme, Stevens-Johnson syndrome, toxic epidermal
necrolysis, epidermolysis bullosa, childhood vulvar pemphigoid, and
bullae induced by mustard gas. Nevi appear mostly in areas of for-
mer epidermal detachment several weeks to months after epithelial
regeneration. It has been presumed that specific cytokines and
growth factors secreted during epidermal regeneration are the cause
of melanocyte proliferation.9
Once they appear, eruptive nevi may remain stable for long peri-
ods (4-38 years), darken, or in contrast, fade and even regress
completely. In the present case, a gradual increase in number and
darkness of the melanocytic nevi has been seen up to 4 years after
the initial injury. The long-lasting progression indicates that factors
other than the transient dysregulation of local growth factors must
be involved.
Porphyrins can generate reactive oxygen species in both the
absence or presence of activating light and therefore can be poten-
tially genotoxic.10 They can also modulate local inflammatory reac-
tions or directly influence the activity of immune cells.11 Yet, in the
literature, there are no observations indicating higher rates of mela-
nocytic nevi and melanomas in patients with porphyrias.
The influence of NBPL on melanocytes is unclear. Several studies
reported enhanced formation of melanocytic nevi,12 but others
found no association between the phototherapy and melanocytic
nevi formation in exposed children.13 After a meta-analysis of obser-
vational studies, Lai and Yew concluded that there was no evidence
of greater risk of developing melanocytic nevi after NBPL,14
although in their comprehensive review of experimental and epi-
demiological data, Olah and colleagues emphasize that greater con-
sideration should be given to long-term side effects when
phototherapy is indicated.15
The role of NBLP in the acute toxic reaction observed in the
present case is obvious, but its role in melanocyte proliferation is
only presumed. Nevertheless, we agree with the authors of the latter
two reports14,15 that the effect of NBLP on melanocytes is an impor-
tant topic that deserves further evaluation (in vitro and in vivo, as
prospective cohort studies with long follow-up).
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